Article info

Download PDFPDF
Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy
  1. Dr T Y Y Lai, Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, 3/F, Hong Kong Eye Hospital, 147K Argyle Street, Kowloon, Hong Kong, People’s Republic of China; tyylai{at}cuhk.edu.hk
View Full Text

Citation

Lai TYY, Chan W, Liu DTL, et al
Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy

Publication history

  • Accepted February 11, 2008
  • First published March 20, 2008.
Online issue publication 
April 25, 2008

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.